Market News AIOpen the app

CarMax reported strong earnings for the second quarter, and its stock, along with others like Iovance Biotherapeutics, went up on Tuesday.

ResultsRead the original at Benzinga
Good for KMX

CarMax earned $1.16 per share against an expected $0.73, and sales were $7.9 billion versus $7.0 billion expected. Both results support a stronger quarter than analysts expected.

KMX · CarMax Inc

AI read · Good for KMX

The AI's read

The results give CarMax evidence of a stronger quarter than analysts expected. Profit per share and sales both beat estimates, and the source names no weaker company result to balance those gains.

IOVA · Iovance Biotherapeutics Inc

AI read · Good for IOVA

The connection

Iovance raised its FY26 sales forecast. That points to expected sales above its earlier plan, supporting a more favorable outlook.

PWP · Perella Weinberg Partners

AI read · Neutral

The connection

Perella Weinberg was reported to be in talks with Piper Sandler about combining. No agreement or terms are reported, so the story does not yet change the firm's outlook.

CCL · Carnival Corporation Ltd

AI read · Good for CCL

The connection

Carnival reported third-quarter results above expectations and raised its FY26 adjusted profit forecast above estimates. Both support a stronger outlook.

BE · Bloom Energy Corp

AI read · Neutral

The connection

Bloom Energy's analyst kept a Hold rating but raised the target price from $229 to $264. Those mixed signals do not show a clear change in the company's business outlook.

Get alerts for KMX

Follow CarMax Inc (KMX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for KMX
Free on the App Store and Google Play, or on the web.